Aurora Cannabis (ACB) Net Income (QoQ) (2017 - 2026)
Aurora Cannabis (ACB) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48,722.05% |
| Dec 31, 2025 | -236.12% |
| Sep 30, 2025 | 124.13% |
| Jun 30, 2025 | 95.54% |
| Mar 31, 2025 | -9,613.72% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | -4,915.79% |
| Jun 30, 2024 | 81,864.67% |
| Mar 31, 2024 | 51.42% |
| Dec 31, 2023 | 99.97% |
| Sep 30, 2023 | 68.45% |
| Dec 31, 2022 | -30.96% |
| Sep 30, 2022 | -640.61% |
| Jun 30, 2022 | 99.83% |
| Mar 31, 2022 | -1,234.18% |
| Dec 31, 2021 | -523.63% |
| Sep 30, 2021 | -1,666.03% |
| Jun 30, 2021 | 100.47% |
| Mar 31, 2021 | 41.40% |
| Dec 31, 2020 | -12,412.24% |